Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BPX-601 |
| Trade Name | |
| Synonyms | GoCART BPX-601|iMC/PSCA-zeta BPX 601|Autologous PSCA CAR T Cells BPX-601 |
| Drug Descriptions |
BPX-601 are autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting human prostate stem cell antigen (PSCA) and the zeta chain of the T-cell receptor (TCRzeta), and a rimiducid-induced co-stimulatory molecule, which activates anti-tumor immune response (PMID: 27824842). |
| DrugClasses | PSCA Immune Cell Therapy 3 |
| CAS Registry Number | NA |
| NCIT ID | C128031 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BPX-601 | BPX-601 | 0 | 1 |
| BPX-601 + Rimiducid | BPX-601 Rimiducid | 0 | 1 |